The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Open accessAbstract
The primary theme emerging from molecular genetic work conducted with Mycobacterium tuberculosis and several other mycobacterial species is that resistance is commonly associated with simple nucleotide alterations in target chromosomal genes rather than with acquisition of new genetic elements encoding antibiotic-altering enzymes. Mutations in an 81-bp region of the gene (rpoB) encoding the beta subunit of RNA polymerase account for rifampin resistance in 96% of M. tuberculosis and many Mycobacterium leprae isolates. Streptomycin resistance in about one-half of M. tuberculosis isolates is associated with missense mutations in the rpsL gene coding for ribosomal protein S12 or nucleotide substitutions in the 16S rRNA gene (rrs). Mutations in the katG gene resulting in catalase-peroxidase amino acid alterations nad nucleotide substitutions in the presumed regulatory region of the inhA locus are repeatedly associated with isoniazid-resistant M. tuberculosis isolates. A majority of fluoroquinolone-resistant M. tuberculosis isolates have amino acid substitutions in a region of the DNA gyrase A subunit homologous to a conserved fluoroquinolone resistance-determining region. Multidrug-resistant isolates of M. tuberculosis arise as a consequence of sequential accumulation of mutations conferring resistance to single therapeutic agents. Molecular strategies show considerable promise for rapid detection of mutations associated with antimicrobial resistance. These approaches are now amenable to utilization in an appropriately equipped clinical microbiology laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., & Sekiya, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2766 · Cited by 3,610
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
Newton, C. R., Graham, A., Heptinstall, L. E., Powell, S. J., Summers, C., Kalsheker, N., Smith, J. C., & Markham, A. F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2503 · Cited by 2,475
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Tuberculosis: Commentary on a Reemergent Killer
Bloom, B. R., & Murray, C. J. L. (1992) · Science · doi:10.1126/science.257.5073.1055 · Cited by 1,373
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
The Molecular Basis of Antibiotic Action
Gale, E. F. (1981) · Medical Entomology and Zoology · Cited by 1,217
Interaction of antibiotics with functional sites in 16S ribosomal RNA
Moazed, D., & Noller, H. F. (1987) · Nature · doi:10.1038/327389a0 · Cited by 1,150
Tuberculosis: Pathogenesis, Protection and Control
(1996) · Nature Medicine · doi:10.1038/nm0296-244b · Cited by 977
The Emergence of Drug-Resistant Tuberculosis in New York City
Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., & Dooley, S. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280801 · Cited by 939
Mycobacterium avium Complex Infection in the Acquired Immunodeficiency Syndrome
Horsburgh, C. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105093241906 · Cited by 927
The global tuberculosis situation and the new control strategy of the World Health Organization
Kochi, A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90017-m · Cited by 843
Genetic disease detection and DNA amplification using cloned thermostable ligase.
Barany, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.189 · Cited by 796
Noller, H. F. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.001003 · Cited by 792
Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution.
Finzel, B. C., Poulos, T. L., & Kraut, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90651-4 · Cited by 713
The Mycobacterium avium complex
Inderlied, C. B., Kemper, C. A., & Bermudez, L. E. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.3.266 · Cited by 687
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Pelletier, H., & Kraut, J. (1992) · Science · doi:10.1126/science.1334573 · Cited by 676
[Epidemiology of tuberculosis].
Neumann, G. (1971) · PubMed · Cited by 523
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Identification by ENDOR of Trp 191 as the Free-Radical Site in Cytochrome c Peroxidase Compound ES
Sivaraja, M., Goodin, D. B., Smith, M., & Hoffman, B. M. (1989) · Science · doi:10.1126/science.2549632 · Cited by 479
Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy.
Salo, W. L., Aufderheide, A. C., Buikstra, J., & Holcomb, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2091 · Cited by 435
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Quinolone antimicrobial agents
(1989) · International Journal of Biochemistry · doi:10.1016/0020-711x(89)90066-9 · Cited by 407
Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
Nightingale, S. D., Cameron, D. W., Gordin, F. M., Sullam, P. M., Cohn, D. L., Chaisson, R. E., Eron, L. J., Sparti, P. D., Bihari, B., Kaufman, D. L., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309163291202 · Cited by 394
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
Takayama, K., & Kilburn, J. O. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1493 · Cited by 369
Finken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Detecting single base substitutions as heteroduplex polymorphisms
White, M. B., Carvalho, M., Derse, D., O'Brien, S. J., & Dean, M. (1992) · Genomics · doi:10.1016/0888-7543(92)90377-5 · Cited by 355
Sequencing of megabase plus DNA by hybridization: Theory of the method
Dramanac, R., Labat, I., Brukner, I., & Crkvenjakov, R. (1989) · Genomics · doi:10.1016/0888-7543(89)90290-5 · Cited by 354
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Kapur, V, Li, L. L., Iordanescu, S., Hamrick, M. R., Wanger, A., Kreiswirth, B. N., & Musser, J. M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1095-1098.1994 · Cited by 317
Self-citationA novel method for nucleic acid sequence determination
Bains, W., & Smith, G. C. (1988) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(88)80246-7 · Cited by 313
Musser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Self-citationA Strategic Plan for the Elimination of Tuberculosis in the United States
(1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420200025009 · Cited by 312
On the mechanism of rifampicin inhibition of RNA synthesis.
McClure, W. R., & Cech, C. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34269-2 · Cited by 310
Nationwide Survey of Drug-Resistant Tuberculosis in the United States
Bloch, A. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510330043032 · Cited by 304
Brown, B. A., Wallace, R. J., Onyi, G. O., De Rosas, V, & Wallace, R. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.180 · Cited by 301
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Snider, D. E., Raviglione, M., & Kochi, A. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch1 · Cited by 288
Skinner, R., Cundliffe, E., & Schmidt, F. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44232-3 · Cited by 263
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T., & Bodmer, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2054 · Cited by 250
Fischl, M. A., Daikos, G. L., Uttamchandani, R. B., Poblete, R. B., Moreno, J. N., Reyes, R. R., Boota, A. M., Thompson, L. M., Cleary, T. J., Oldham, S. A., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-184 · Cited by 248
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis
Siddiqi, S. H., Libonati, J. P., & Middlebrook, G. (1981) · Journal of Clinical Microbiology · doi:10.1128/jcm.13.5.908-912.1981 · Cited by 242 · cited 1×
“MICs were determined by the BACTEC 460 radiometric method (142), and the following MICs were obtained for wild-type organisms: RIF, 0.”
MethodIsoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis
Morris, S., Bai, G. H., Suffys, P., Portillo-Gomez, L., Fairchok, M., & Rouse, D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.954 · Cited by 231
Herzog, B. (1998) · Respiration · doi:10.1159/000029220 · Cited by 230
Mahmoudi, A. (1993) · JAMA · doi:10.1001/jama.270.1.65 · Cited by 219
Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli
Middlebrook, G., & Cohn, M. L. (1953) · Science · doi:10.1126/science.118.3063.297 · Cited by 217
Heym, B., Zhang, Y., Poulet, S., Young, D., & Cole, S. T. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.13.4255-4259.1993 · Cited by 214
Funatsu, G., & Wittmann, H. G. (1972) · Journal of Molecular Biology · doi:10.1016/0022-2836(72)90108-8 · Cited by 212
Present aspects of bacterial resistance in tuberculosis.
Canetti, G. (1965) · PubMed · doi:10.1164/arrd.1965.92.5.687 · Cited by 211
Kapur, V., Li, L., Hamrick, M. R., et al. (1995) · PubMed · Cited by 203
Molecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Jin, D. J., & Gross, C. A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.9.5229-5231.1989 · Cited by 165
Is Mycobacterium tuberculosis 15,000 Years Old?
Kapur, V., Whittam, T. S., & Musser, J. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1348 · Cited by 165
Self-citationMutations in 16S ribosomal RNA disrupt antibiotic-RNA interactions.
De Stasio, E. A., Moazed, D., Noller, H. F., & Dahlberg, A. E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03494.x · Cited by 164
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Antimicrobial Agents and Susceptibility Testing
Chengappa, M. M. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-161775-2.50039-6 · Cited by 154
Drug Susceptibility in the Chemotherapy of Mycobacterial Infections
Heifets, L. B., & Cynamon, M. H. (1991) · Cited by 151
Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli.
Bergler, H., Wallner, P., Ebeling-Keil, A., Leitinger, B., Fuchsbichler, S., Aschauer, H., Kollenz, G., Högenauer, G., & Turnowsky, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37485-9 · Cited by 151
Drug-resistant tuberculosis: laboratory issues
Vareldzis, B., Grosset, J. H. E., Kantor, I. N., Crofton, J., Laszlo, A., Felten, M., Raviglione, M. C., & Kochi, A. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90096-5 · Cited by 150
Smith, P. G., & Moss, A. R. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch4 · Cited by 142
Brown, B. A., Wallace, R. J., & Onyi, G. O. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1987 · Cited by 124
Bodmer, T., Zürcher, G., Imboden, P., et al. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.345 · Cited by 123
Quémard, A., Lacave, C. S., & Lanéelle, G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1035 · Cited by 121
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
Ordway, D. J., Sonnenberg, M. G., Donahue, S. A., Belisle, J. T., & Orme, I. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.741-743.1995 · Cited by 120
Allen, P. N., & Noller, H. F. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90509-3 · Cited by 120
Permeability Barrier to Rifampin in Mycobacteria
Hui, J., Gordon, N. C., & Kajioka, R. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.773 · Cited by 117
O'Brien, R. J., Lyle, M. A., & Snider, D. E. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.3.519 · Cited by 116
Current practices in mycobacteriology: results of a survey of state public health laboratories
Huebner, R. E., Good, R. C., & Tokars, J. I. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.771-775.1993 · Cited by 115
Cockerill, F. R., Uhl, J. R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., & Kline, B. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.240 · Cited by 114
Tuberculosis Symposium: Emerging Problems and Promise
Ellner, J. J., Hinman, A. R., Dooley, S. W., Fischl, M. A., Sepkowitz, K. A., Goldberger, M. J., Shinnick, T. M., Iseman, M. D., & Jacobs, W. R. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.537 · Cited by 111
Tetracycline resistance determinants in Mycobacterium and Streptomyces species
Pang, Y., Brown, B. A., STEINGRUBE, V. A., Wallace, R. J., & Roberts, M. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1408 · Cited by 109
Inhibition by Ethambutol of Mycolic Acid Transfer into the Cell Wall of Mycobacterium smegmatis
Takayama, K., Armstrong, E. L., Kunugi, K. A., & Kilburn, J. O. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.2.240 · Cited by 108
Honoré, N., Bergh, S., Chanteau, S., Doucet‐Populaire, F., Eiglmeir, K., Garnier, T., Georges, C., Launois, P., Limpaiboon, T., Newton, S. M. C., et al. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01112.x · Cited by 107
RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance
Ovchinnikov, Y. A., MONASTYRSKAYA, G. S., Guriev, S. O., Nf, K., Sverdlov, E. D., Gragerov, A., Bass, I. A., Kiver, I. F., Moiseeva, E. P., Igumnov, V. N., et al. (1983) · Molecular and General Genetics MGG · doi:10.1007/bf00330662 · Cited by 105
Levin, M. E., & Hatfull, G. F. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01572.x · Cited by 103
Clarithromycin Minimal Inhibitory and Bactericidal Concentrations against Mycobacterium avium
Heifets, L. B., Lindholm-Levy, P. J., & Comstock, R. D. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.856 · Cited by 100
Cohn, M. L., Kovitz, C., ODA, U., & Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.70.4.641 · Cited by 98
Peroxidase-mediated oxidation of isoniazid
Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C., et al. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.399 · Cited by 94
Thomas, J.-P., Baughn, C., WILKINSON, R. G., & Shepherd, R. G. (1961) · PubMed · doi:10.1164/arrd.1961.83.6.891 · Cited by 92
envM genes of Salmonella typhimurium and Escherichia coli
Turnowsky, F., Fuchs, K. P., Jeschek, C., & Högenauer, G. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.12.6555-6565.1989 · Cited by 89
Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C., & Merola, A. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.404 · Cited by 89
Lisitsyn, N. A., Sverdlov, E. D., Moiseeva, E. P., Danilevskaya, O. N., & Nikiforov, V. (1984) · Molecular and General Genetics MGG · doi:10.1007/bf00334112 · Cited by 84
Organization of rRNA genes in Mycobacterium bovis BCG
Suzuki, Y., Yoshinaga, K., Ono, Y., et al. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.2.839-843.1987 · Cited by 78
Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium tuberculosis bcg
Winder, F. G., Collins, P. B., & Whelan, D. (1971) · Journal of General Microbiology · doi:10.1099/00221287-66-3-379 · Cited by 75
Whelen, A. C., Felmlee, T. A., Hunt, J. M., Williams, D. L., Roberts, G. D., Stockman, L., & Persing, D. H. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.556-561.1995 · Cited by 74
Stoeckle, M. Y., Guan, L. L., Riegler, N., Weitzman, I., Kreiswirth, B. N., Kornblum, J. S., Laraque, F., & Riley, L. W. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1063 · Cited by 70
Dickinson, J. M., & MITCHISON, D. A. (1987) · Tubercle · doi:10.1016/0041-3879(87)90053-5 · Cited by 70
LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.
BRUNA, C. D., SCHIOPPACASSI, G., UNGHERI, D., et al. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.1502 · Cited by 69
Forbes, M., Kuck, N. A., & Peets, E. A. (1962) · Journal of Bacteriology · doi:10.1128/jb.84.5.1099-1103.1962 · Cited by 63
Sequences of the envM gene and of two mutated alleles in Escherichia coli
Bergler, H., Högenauer, G., & Turnowsky, F. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-10-2093 · Cited by 62
A Ribosomal Gene Mutation in Streptomycin-ResistantMycobacterium tuberculosis Isolates
Douglass, J., & Steyn, L. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1505 · Cited by 62
Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control
Zhang, Y., & Young, D. B. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90117-a · Cited by 61
Forbes, M., Kuck, N. A., & Peets, E. A. (1965) · Journal of Bacteriology · doi:10.1128/jb.89.5.1299-1305.1965 · Cited by 59
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid
Rosner, J. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2251 · Cited by 51
Leclerc, D., Melançon, P., & Brakier‐Gingras, L. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.3973 · Cited by 46
Rosner, J. L., & Storz, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1829 · Cited by 41
Williams, D. L., Gillis, T. P., & Portaels, F. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb00542.x · Cited by 40
Morris, S. L., Nair, J., & Rouse, D. A. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-11-2363 · Cited by 40
Kenney, T. J., & Churchward, G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.19.6153-6156.1994 · Cited by 39
Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991
Sepkowitz, K. A., Telzak, E. E., Recalde, S., Armstrong, D., & the New York City Area Tuberculosis Working Group (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.5.755 · Cited by 39
Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug
Silve, G., Valero-Guillén, P. L., Quémard, A., Dupont, M.-A., Daffé, M., & Lanéelle, G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1536 · Cited by 32
Effects of Ethambutol on Phospholipid Metabolism in Mycobacterium smegmatis
Kilburn, J. O., Takayama, K., Armstrong, E. L., & Greenberg, J. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.2.346 · Cited by 29
Some observations on the genetics of isoniazid resistance in the tubercle bacilli.
David, H. L., & Newman, C. M. (1971) · PubMed · doi:10.1164/arrd.1971.104.4.508 · Cited by 28
Karlson, A. G. (2015) · American Review of Respiratory Disease · Cited by 18
The ethionamide sensitivity of british pre-treatment strains of mycobacterium tuberculosis
Lefford, M. J. (1966) · Tubercle · doi:10.1016/s0041-3879(66)80036-3 · Cited by 16
Nonspecific Ionic Inhibition of Ethambutol Binding by Mycobacterium smegmatis
Beggs, W. H., & Andrews, F. A. (1973) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.4.2.115 · Cited by 16
Myambutol: Chemistry, Pharmacology, and Toxicology
Kanther, R. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000386822 · Cited by 11
Clinical Experience with Ethambutol
Wilson, T. M. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000386824 · Cited by 10
Cited by
Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell, G., & Russell, A. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.147 · Cited by 4,780
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Self-citationSreevatsan, S., Pan, X., Stockbauer, K. E., Connell, N. D., Kreiswirth, B. N., Whittam, T. S., & Musser, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9869 · Cited by 1,024
Self-citationThe Continuing Challenges of Leprosy
Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., & Williams, D. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.338-381.2006 · Cited by 928
Davey, H. M., & Kell, D. B. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.641-696.1996 · Cited by 879
Metadata
- Authors
- Musser, J. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1995-10
- Volume
- 8
- Issue
- 4
- Pages
- 496-514
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2109751189
- Cited by
- 621
- References
- 117
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.